Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Jessica Price Advanced Cell and Molecular Biology Lake Forest College
Cell Structure. Cytoplasm  All of the cellular contents between the plasma membrane and the nucleus.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?
Intracellular Compartments ER, Golgi, Endsomes, Lysosomes and Peroxisomes.
Introduction Cells must have specific ways to transport, store, and breakdown biological molecules. In humans, there are many DNA mutations that lead to.
Α-Synuclein Interaction with Phospholipids: Possible Implications for Parkinson’s Disease Literature Seminar by Jessica L. Anderson.
September 13th BIOS E108 Parkinson’s disease (PD) -Pathology -Diagnosis -  -synuclein.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures.
NERVOUS SYSTEM DISEASES NOTES. CEREBRAL PALSY: WHAT IS IT? Muscle spasms/tightness Involuntary movements Problems with balance Awkward gait Can be minor.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
HEXA and Tay-Sachs Disease
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
The Importance of Non-conserved Regions in Protein Remodeling by the E. coli Molecular Chaperone, ClpB Zakiya Qualls.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
Parkinson’s Disease superKAT :).
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
1 Introduction(1/2)  Eukaryotic cells can synthesize up to 10,000 different kinds of proteins  The correct transport of a protein to its final destination.
 Phospholipid bilayer  “Mosaic” of proteins The fluid-mosaic model.
New Cellular Models for Drug Discovery in Alzheimer’s Disease Jordan L. Holtzman, M.D.,Ph.D. 1,2,3 (1) Division of Environmental Health Sciences (2) Departments.
Trafficking and processing of APP  -secretase. Intracellular trafficking of APP: relation to its physiological function?
A mitochondrial quality control pathway revealed from studies of familial Parkinson’s Disease genes Leo Pallanck Department of Genome Sciences.
Trafficking and processing of APP  and  -secretase.
Identification of Novel Factors Involved in Vesicle Formation at the Multivesicular Body in Yeast Erika Hanson Stevens Lab.
Javad Jamshidi Fasa University of Medical Sciences, October 2015 Eukaryotic Cell Organelles and Organization.
Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language.
Mitochondrial function in Cell death in PD. Pathology Loss of SN pigmented dopamine neurons Lewy bodies Lewy neurites-multiple brain regions Lewy bodies.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
By Katelyn Chaimson and Sean Guyot
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Alzheimer’s Disease and the influence of Presenilin 1 By Tony Cortez.
AP Biology Eukaryotic Genome Control Mechanisms for Gene expression.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Pathogenesis and pathology of parkinsonism
Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.
Alzheimer’s Disease and the influence of Presenilin 1
4-1 Protein Synthesis Is a Major Function of Cells.
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
Parkinson’s Disease.
Preston Ge Institute for Cell Engineering
CLINICAL CORRELATIONS
Protein conformational disorders
CLINICAL CORRELATIONS
Advisor: Shubhik K. DebBurman Department of Biology
III. Parkinson Disease.
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Long Term Effects of Concussions
Alpha-synuclein in Parkinson's disease
Parkinson’s Common neurodegenerative disorder ~10-20/1000
What does this protein make up or do?
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Parkinson’s Diseased Proteins in Relation to Autophagy
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
PowerPoint by Jody Baker
CLINICAL CORRELATIONS
STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Parkinson's Disease Neuron
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Course Business Writing Assignment 8 was due before class today.
PD-associated gene products and their prospective sites of cellular function PD is hypothesized to be a consequence of the dysfunction of intersecting.
Presentation transcript:

Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009

Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language problems Stiff muscles Ataxia Personality changes Decline in mental abilities Symptoms of Neurodegenerative Diseases

Road Map INTRODUCTION: Neurodegenerative Diseases Culprit Protein in Parkinson’s Protein Degradation Pathways Endocytosis and ESCRT Hypothesis and Model Organism RESULTS: Three Aims & Goals DISCUSSION: Major Findings

Introduction to Parkinson’s Disease

Common Problem in NDD Parkinson’s Disease Alzheimer’s Disease Huntington’s Disease Prion Disease ALS  -Synuclein Amyloid-  peptide Huntingtin Prion protein SOD1 Misfolding & Aggregation Cell Death DiseaseCulprit Protein

Parkinson’s Disease 4 million people affected Classic symptoms: Resting tremors Muscular rigidity No known cure Muhammad Ali & Michael J. Fox

SPORADICFAMILIAL Normal  -synuclein Misfolded Accumulated Genes:  -synuclein parkin UCH-L1 DJ-1 PINK1 LRRK2 DNA Point mutations Toxins Environmental factors A30P, A53T, E46K Normal (Wild Type)  -synuclein CELL DEATH Sporadic vs. Familial PD >90%<10%

What Happens in the PD Brain? My Interest in  -Syn: Lewy Bodies:  - Synuclein inclusions Basal Ganglia Substantia Nigra Motor Cortex Less movement! Muscle

Culprit Protein:  -Synuclein 140 amino acid protein Associated with: 1.Cytoplasm 2.Synaptic Machinery 3.Extra cellular matrix 4.Secretory pathway Loves to aggregate and bind to membrane

Proof of  -Synuclein Involvement: PD-like symptoms WT & familial mutants (A30P & A53T) Feany, M., et al. (2000). Masilah, E., et al. (2000). Lasko, M., et al. (2003).

What causes  -synuclein toxicity? Essential to examine  -synuclein degradation routes Alpha-synuclein THERAPY! Is  -synuclein accumulation causing PD? Normal  -synuclein Misfolded Aggregated  -Synuclein accumulates

Proteins 1.VERY Important 2. Shape and Function Normal Protein Misfolded Old

Degradation Pathways Proteasome Lysosome Degrades proteins from cytoplasm or nucleus Degrades proteins from plasma membrane, organelles or outside cell  -synuclein literature: Evidence UCHL1 parkin Knowing where  -synuclein is found, which mechanism will degrade it?

Lysosome

Outside Cell Inside Cell Why Endocytosis? Dixon et al. (2005) Lee et al. (2008) Sharma et al. (2006) Lysosome

Cell Cytoplasm Late Endosome Lysosome Early Endosome MVB Outside Endocytosis Golgi

ESCRT Pathway Endosomal Sorting Complexes Required for Transport MVB Cytoplasm ? ?

Gap in Knowledge and Hypothesis My hypothesis is that  -synuclein interacts with the pre-ESCRT proteins while using the MVB/endosome pathway as a route to the lysosome.

Model Organism Budding Yeast (S. cerevisiae) Easy to grow Cost effective Genome sequence available ESCRT genes conserved in humans MVB/endosome pathway best studied in yeast

Experimental Design Endocytosis Intact No vps34 No vps27 Budding yeast with… vs. and CONTROL Does  -synuclein… 1. aggregate more 2. accumulate more 3. cause cell toxicity …in endocytosis compromised yeasts

Results: What I Found

What I found:

Localization: GFP Method: WTA30P E46K GFP 24 hrs 48 hrs Endocytosis Intact WTA30P E46KGFP 24 hrs 48 hrs No vps34

Accumulation: Method: V5 PGK 24 hr GAL Heat SDS Class Beads Protein Gel Membrane Y Y Anti-PGK Anti-V5 BY4741 vps34  WT A30P E46K GFP anti-PGK MW anti-V5 WT A30P E46K GFP Method: V5 PGK 24 hr GAL Heat SDS Class Beads Protein GelMembrane Y Y Anti-V5 24 hr GLU 0 hr GLU 6 hr GLU 12 hr GLU BY4741 vps34  Gal MW Glu WT Loss of Induction anti-PGK anti-V5

Cell Toxicity: Method: Spectrophotometer Culture GAL Time Absorbance Time (hrs) No vps34

Mounting Evidence: vps22 vps32 vps2 Hse1

Final Thoughts  -synuclein Hypothesis supported! Hardships, inconvenience and costs

Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009

Acknowledgements BIOL 324: Keith, Carlos, Will, Rebecca, Alina and Danny STOCKROOM: Beth, Tasheka, Kaylyn, Jordanah, and Madhavi Lastly: Mike and Dr. DebBurman!

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?

Two Very Important Proteins vps27: forms complex with Hse1p; Required for recycling Golgi proteins, forming lumenal membranes and sorting ubiquitinated proteins vps34: Kinase responsible for the synthesis of one phospholipid; forms membrane complex with Vps15p to regulate protein sorting Yeast Genome Database vps34 vps27 MVB Cargo Endosome Lumen Off to ESCRT-I Endosome Membrane